{"id":16523,"date":"2011-05-27T07:57:51","date_gmt":"2011-05-27T07:57:51","guid":{"rendered":"https:\/\/legaladvantage.net\/?p=16523"},"modified":"2024-01-17T08:00:32","modified_gmt":"2024-01-17T08:00:32","slug":"uspto-studying-therasense-v-becton-dickinson-decision","status":"publish","type":"post","link":"https:\/\/legaladvantage.net\/2011\/05\/uspto-studying-therasense-v-becton-dickinson-decision\/","title":{"rendered":"USPTO Studying Therasense v. Becton, Dickinson Decision"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"16523\" class=\"elementor elementor-16523\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6b09bceb e-flex e-con-boxed e-con e-parent\" data-id=\"6b09bceb\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a9859f3 elementor-widget elementor-widget-heading\" data-id=\"a9859f3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-xl\">USPTO Studying Therasense v. Becton, Dickinson Decision\n<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-42dd5e5 elementor-widget elementor-widget-text-editor\" data-id=\"42dd5e5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h2>USPTO PRESS RELEASE<\/h2><p>Washington \u2013 Today the United States Patent and Trademark Office (USPTO) announced that it is carefully studying the important en banc decision by the U.S. Court of Appeals for the Federal Circuit in the case of Therasense v. Becton, Dickinson to assess how it may impact agency practices and procedures. The agency also announced that it expects to soon issue guidance to applicants related to the prior art and information they must disclose to the Office in view of Therasense.<\/p><p>\u201cWe are now studying the potential impact of Therasense v. Becton, Dickinson on Office practice, and we expect to soon issue guidance to applicants regarding the materials they must submit to the Office under their duty of disclosure,\u201d said Under Secretary of Commerce for Intellectual Property and Director of the USPTO David Kappos.<\/p><p>The Therasense decision concerns the standards for inequitable conduct, including the materiality and intent prongs. The Court\u2019s decision resolves uncertainties in many aspects of how district courts must apply the inequitable conduct doctrine. It also directly affects applicant behavior in front of the USPTO and, in particular, their disclosure of information relevant to the patentability of their inventions.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>USPTO Studying Therasense v. Becton, Dickinson Decision USPTO PRESS RELEASE Washington \u2013 Today the United States Patent and Trademark Office (USPTO) announced that it is carefully studying the important en banc decision by the U.S. Court of Appeals for the Federal Circuit in the case of Therasense v. Becton, Dickinson to assess how it may [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","footnotes":""},"categories":[],"tags":[],"class_list":["post-16523","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>USPTO Studying Therasense v. Becton, Dickinson Decision - Legal Advantage<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/legaladvantage.net\/2011\/05\/uspto-studying-therasense-v-becton-dickinson-decision\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"USPTO Studying Therasense v. Becton, Dickinson Decision - Legal Advantage\" \/>\n<meta property=\"og:description\" content=\"USPTO Studying Therasense v. Becton, Dickinson Decision USPTO PRESS RELEASE Washington \u2013 Today the United States Patent and Trademark Office (USPTO) announced that it is carefully studying the important en banc decision by the U.S. Court of Appeals for the Federal Circuit in the case of Therasense v. Becton, Dickinson to assess how it may [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/legaladvantage.net\/2011\/05\/uspto-studying-therasense-v-becton-dickinson-decision\/\" \/>\n<meta property=\"og:site_name\" content=\"Legal Advantage\" \/>\n<meta property=\"article:published_time\" content=\"2011-05-27T07:57:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-17T08:00:32+00:00\" \/>\n<meta name=\"author\" content=\"legaladvantage\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"legaladvantage\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/legaladvantage.net\\\/2011\\\/05\\\/uspto-studying-therasense-v-becton-dickinson-decision\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/legaladvantage.net\\\/2011\\\/05\\\/uspto-studying-therasense-v-becton-dickinson-decision\\\/\"},\"author\":{\"name\":\"legaladvantage\",\"@id\":\"https:\\\/\\\/legaladvantage.net\\\/#\\\/schema\\\/person\\\/265948e08c42b20a73df94b3f39f4e54\"},\"headline\":\"USPTO Studying Therasense v. Becton, Dickinson Decision\",\"datePublished\":\"2011-05-27T07:57:51+00:00\",\"dateModified\":\"2024-01-17T08:00:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/legaladvantage.net\\\/2011\\\/05\\\/uspto-studying-therasense-v-becton-dickinson-decision\\\/\"},\"wordCount\":209,\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/legaladvantage.net\\\/2011\\\/05\\\/uspto-studying-therasense-v-becton-dickinson-decision\\\/\",\"url\":\"https:\\\/\\\/legaladvantage.net\\\/2011\\\/05\\\/uspto-studying-therasense-v-becton-dickinson-decision\\\/\",\"name\":\"USPTO Studying Therasense v. Becton, Dickinson Decision - Legal Advantage\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/legaladvantage.net\\\/#website\"},\"datePublished\":\"2011-05-27T07:57:51+00:00\",\"dateModified\":\"2024-01-17T08:00:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/legaladvantage.net\\\/#\\\/schema\\\/person\\\/265948e08c42b20a73df94b3f39f4e54\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/legaladvantage.net\\\/2011\\\/05\\\/uspto-studying-therasense-v-becton-dickinson-decision\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/legaladvantage.net\\\/2011\\\/05\\\/uspto-studying-therasense-v-becton-dickinson-decision\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/legaladvantage.net\\\/2011\\\/05\\\/uspto-studying-therasense-v-becton-dickinson-decision\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/legaladvantage.net\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"USPTO Studying Therasense v. Becton, Dickinson Decision\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/legaladvantage.net\\\/#website\",\"url\":\"https:\\\/\\\/legaladvantage.net\\\/\",\"name\":\"Legal Advantage\",\"description\":\"Intellectual Property &amp; Legal Support Services\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/legaladvantage.net\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/legaladvantage.net\\\/#\\\/schema\\\/person\\\/265948e08c42b20a73df94b3f39f4e54\",\"name\":\"legaladvantage\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/58b4c8871c8c764275b19a20cd779f8ced96d8e492b1c675a59645896eaa64d3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/58b4c8871c8c764275b19a20cd779f8ced96d8e492b1c675a59645896eaa64d3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/58b4c8871c8c764275b19a20cd779f8ced96d8e492b1c675a59645896eaa64d3?s=96&d=mm&r=g\",\"caption\":\"legaladvantage\"},\"sameAs\":[\"https:\\\/\\\/legaladvantage.net\"],\"url\":\"https:\\\/\\\/legaladvantage.net\\\/author\\\/legaladvantage\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"USPTO Studying Therasense v. Becton, Dickinson Decision - Legal Advantage","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/legaladvantage.net\/2011\/05\/uspto-studying-therasense-v-becton-dickinson-decision\/","og_locale":"en_US","og_type":"article","og_title":"USPTO Studying Therasense v. Becton, Dickinson Decision - Legal Advantage","og_description":"USPTO Studying Therasense v. Becton, Dickinson Decision USPTO PRESS RELEASE Washington \u2013 Today the United States Patent and Trademark Office (USPTO) announced that it is carefully studying the important en banc decision by the U.S. Court of Appeals for the Federal Circuit in the case of Therasense v. Becton, Dickinson to assess how it may [&hellip;]","og_url":"https:\/\/legaladvantage.net\/2011\/05\/uspto-studying-therasense-v-becton-dickinson-decision\/","og_site_name":"Legal Advantage","article_published_time":"2011-05-27T07:57:51+00:00","article_modified_time":"2024-01-17T08:00:32+00:00","author":"legaladvantage","twitter_card":"summary_large_image","twitter_misc":{"Written by":"legaladvantage","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/legaladvantage.net\/2011\/05\/uspto-studying-therasense-v-becton-dickinson-decision\/#article","isPartOf":{"@id":"https:\/\/legaladvantage.net\/2011\/05\/uspto-studying-therasense-v-becton-dickinson-decision\/"},"author":{"name":"legaladvantage","@id":"https:\/\/legaladvantage.net\/#\/schema\/person\/265948e08c42b20a73df94b3f39f4e54"},"headline":"USPTO Studying Therasense v. Becton, Dickinson Decision","datePublished":"2011-05-27T07:57:51+00:00","dateModified":"2024-01-17T08:00:32+00:00","mainEntityOfPage":{"@id":"https:\/\/legaladvantage.net\/2011\/05\/uspto-studying-therasense-v-becton-dickinson-decision\/"},"wordCount":209,"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/legaladvantage.net\/2011\/05\/uspto-studying-therasense-v-becton-dickinson-decision\/","url":"https:\/\/legaladvantage.net\/2011\/05\/uspto-studying-therasense-v-becton-dickinson-decision\/","name":"USPTO Studying Therasense v. Becton, Dickinson Decision - Legal Advantage","isPartOf":{"@id":"https:\/\/legaladvantage.net\/#website"},"datePublished":"2011-05-27T07:57:51+00:00","dateModified":"2024-01-17T08:00:32+00:00","author":{"@id":"https:\/\/legaladvantage.net\/#\/schema\/person\/265948e08c42b20a73df94b3f39f4e54"},"breadcrumb":{"@id":"https:\/\/legaladvantage.net\/2011\/05\/uspto-studying-therasense-v-becton-dickinson-decision\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/legaladvantage.net\/2011\/05\/uspto-studying-therasense-v-becton-dickinson-decision\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/legaladvantage.net\/2011\/05\/uspto-studying-therasense-v-becton-dickinson-decision\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/legaladvantage.net\/"},{"@type":"ListItem","position":2,"name":"USPTO Studying Therasense v. Becton, Dickinson Decision"}]},{"@type":"WebSite","@id":"https:\/\/legaladvantage.net\/#website","url":"https:\/\/legaladvantage.net\/","name":"Legal Advantage","description":"Intellectual Property &amp; Legal Support Services","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/legaladvantage.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/legaladvantage.net\/#\/schema\/person\/265948e08c42b20a73df94b3f39f4e54","name":"legaladvantage","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/58b4c8871c8c764275b19a20cd779f8ced96d8e492b1c675a59645896eaa64d3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/58b4c8871c8c764275b19a20cd779f8ced96d8e492b1c675a59645896eaa64d3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/58b4c8871c8c764275b19a20cd779f8ced96d8e492b1c675a59645896eaa64d3?s=96&d=mm&r=g","caption":"legaladvantage"},"sameAs":["https:\/\/legaladvantage.net"],"url":"https:\/\/legaladvantage.net\/author\/legaladvantage\/"}]}},"_links":{"self":[{"href":"https:\/\/legaladvantage.net\/wp-json\/wp\/v2\/posts\/16523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/legaladvantage.net\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/legaladvantage.net\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/legaladvantage.net\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/legaladvantage.net\/wp-json\/wp\/v2\/comments?post=16523"}],"version-history":[{"count":4,"href":"https:\/\/legaladvantage.net\/wp-json\/wp\/v2\/posts\/16523\/revisions"}],"predecessor-version":[{"id":16527,"href":"https:\/\/legaladvantage.net\/wp-json\/wp\/v2\/posts\/16523\/revisions\/16527"}],"wp:attachment":[{"href":"https:\/\/legaladvantage.net\/wp-json\/wp\/v2\/media?parent=16523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/legaladvantage.net\/wp-json\/wp\/v2\/categories?post=16523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/legaladvantage.net\/wp-json\/wp\/v2\/tags?post=16523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}